58 related articles for article (PubMed ID: 1718472)
1. Toward nonpeptidal substance P mimetic analogues: design, synthesis, and biological activity.
Chorev M; Roubini E; Gilon C; Selinger Z
Biopolymers; 1991 May; 31(6):725-33. PubMed ID: 1718472
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological activity, and conformational analysis of [pGlu6,N-MePhe8,Aib9] substance P (6-11): a selective agonist for the NK-3 receptor.
Tallon M; Ron D; Halle D; Amodeo P; Saviano G; Temussi PA; Selinger Z; Naider F; Chorev M
Biopolymers; 1993 Jun; 33(6):915-26. PubMed ID: 7686410
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P.
Byk G; Halle D; Zeltser I; Bitan G; Selinger Z; Gilon C
J Med Chem; 1996 Aug; 39(16):3174-8. PubMed ID: 8759639
[TBL] [Abstract][Full Text] [Related]
4. Replacement of phe(8) in substance P by tyr (Tyr(8)-SP) alters the conformation of the peptide in DMSO, water, and lipid bilayers.
Patel AB; Srivastava S; Coutinho E; Phadke RS
Biopolymers; 1999 Nov; 50(6):602-12. PubMed ID: 10508963
[TBL] [Abstract][Full Text] [Related]
5. Backbone cyclization of the C-terminal part of substance P. Part 1: The important role of the sulphur in position 11.
Bitan G; Zeltser I; Byk G; Halle D; Mashriki Y; Gluhov EV; Sukhotinsky I; Hanani M; Selinger Z; Gilon C
J Pept Sci; 1996; 2(4):261-9. PubMed ID: 9231334
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of substance P using molecular dynamics and NMR spectroscopy.
Corcho FJ; Salvatella X; Canto J; Giralt E; Perez JJ
J Pept Sci; 2007 Nov; 13(11):728-41. PubMed ID: 17847018
[TBL] [Abstract][Full Text] [Related]
7. A novel computer modeling approach to the structures of small bioactive peptides: the structure of gonadotropin releasing hormone.
Gupta HM; Talwar GP; Salunke DM
Proteins; 1993 May; 16(1):48-56. PubMed ID: 8497483
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
9. Characterization of substance P-membrane interaction by transferred nuclear Overhauser effect.
Augé S; Bersch B; Tropis M; Milon A
Biopolymers; 2000 Oct; 54(5):297-306. PubMed ID: 10935970
[TBL] [Abstract][Full Text] [Related]
10. [Conformational analysis of tachykinins. I. N-terminal fragments of substance P, physalemin, hylambatin, and uperolein].
Avanov AIa
Bioorg Khim; 1991 May; 17(5):637-46. PubMed ID: 1722675
[TBL] [Abstract][Full Text] [Related]
11. Systematic study of substance P analogs. II. Rapid screening of 512 substance P stereoisomers for binding to NK1 receptor.
Wang JX; Dipasquale AJ; Bray AM; Maeji NJ; Spellmeyer DC; Geysen HM
Int J Pept Protein Res; 1993 Oct; 42(4):392-9. PubMed ID: 7503964
[TBL] [Abstract][Full Text] [Related]
12. CD, 1H NMR and molecular modeling studies of the interaction of Ca2+ with substance P and Ala7-substance P in a non-polar solvent.
Qi XF; Zhorov BS; Ananthanarayanan VS
J Pept Sci; 2000 Feb; 6(2):57-83. PubMed ID: 10718128
[TBL] [Abstract][Full Text] [Related]
13. Backbone cyclization: A new method for conferring conformational constraint on peptides.
Gilon C; Halle D; Chorev M; Selinger Z; Byk G
Biopolymers; 1991 May; 31(6):745-50. PubMed ID: 1718473
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel NK-1 tachykinin receptor antagonists: the use of cycloalkyl amino acids as a template.
Sisto A; Bonelli F; Centini F; Fincham CI; Potier E; Monteagudo E; Lombardi P; Arcamone F; Goso C; Manzini S
Biopolymers; 1995 Oct; 36(4):511-24. PubMed ID: 7578945
[TBL] [Abstract][Full Text] [Related]
15. Conformational and biological characterization of human parathyroid hormone hPTH(1-34) analogues containing beta-amino acid residues in positions 17-19.
Schievano E; Mammi S; Carretta E; Fiori N; Corich M; Bisello A; Rosenblatt M; Chorev M; Peggion E
Biopolymers; 2003 Dec; 70(4):534-47. PubMed ID: 14648764
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of potent cyclic hexapeptide NK-1 antagonists. Use of a minilibrary in transforming a peptidal somatostatin receptor ligand into an NK-1 receptor ligand via a polyvalent peptidomimetic.
Hirschmann R; Yao W; Cascieri MA; Strader CD; Maechler L; Cichy-Knight MA; Hynes J; van Rijn RD; Sprengeler PA; Smith AB
J Med Chem; 1996 Jun; 39(13):2441-8. PubMed ID: 8691440
[TBL] [Abstract][Full Text] [Related]
17. Ghrelin receptor inverse agonists: identification of an active peptide core and its interaction epitopes on the receptor.
Holst B; Lang M; Brandt E; Bach A; Howard A; Frimurer TM; Beck-Sickinger A; Schwartz TW
Mol Pharmacol; 2006 Sep; 70(3):936-46. PubMed ID: 16798937
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of SP[6-11] and its analogs using simulated annealing.
Bogár F; Leitgeb B; Paragi G; Orosz A; Penke B
Biopolymers; 2005 May; 78(1):35-45. PubMed ID: 15786438
[TBL] [Abstract][Full Text] [Related]
19. Conformational analysis of the C-terminal Gly-Leu-Met-NH2 tripeptide of substance P bound to the NK-1 receptor.
Sagan S; Quancard J; Lequin O; Karoyan P; Chassaing G; Lavielle S
Chem Biol; 2005 May; 12(5):555-65. PubMed ID: 15911376
[TBL] [Abstract][Full Text] [Related]
20. A design approach to the structural analysis of interleukin-2.
Ciardelli TL; Landgraf B; Gadski R; Strnad J; Cohen FE; Smith KA
J Mol Recognit; 1988 Feb; 1(1):42-7. PubMed ID: 3273651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
